today announced the enrollment of the first patient in their Early Feasibility and Safety Study, investigating the Bashir[TM] Endovascular Catheter for the treatment of submassive
pulmonary embolism (PE).
Management options beyond therapeutic anticoagulation for acute massive and submassive
PE (RV dysfunction in the absence of hypotension) include the administration of a systemic thrombolytic agent.
It is subdivided into massive, submassive
, and nonmassive categories.
Patients are classified as massive, submassive
, and low-risk, based on hypotension, RV dysfunction, and/or cardiac biomarkers .
Potential role of systemic thrombolysis in acute submassive
intermediate risk pulmonary embolism: review and future perspective.
SAN DIEGO -- One year after implementation, a pulmonary embolism response team (PERT) is making a significant difference in care of patients with submassive
pulmonary embolism (PE) and evidence of right ventricular (RV) dysfunction at the Christiana (Del.) Medical Center.
PE is commonly classified as massive (high-risk), submassive
(intermediate-risk) and low risk to help determine the required treatment.
Patients presenting with submassive
PE are normotensive with clinical indications of right ventricular strain.
MD Treatment of Massive or Submassive
Acute Pulmonary Embolism With Catheter-Directed Thrombolysis.
Primary therapy with fibrinolysis or embolectomy is generally considered for patients presenting with either massive or submassive
Our patient had symptomatic DVT on the right lower limb and accompanying submassive
 conducted a randomized, controlled pilot study in 2016 comparing IV perfusion of TXA to placebo in 66 patients with submassive